GlucoTrack is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. Co. has developed a non-invasive glucose monitor, the GlucoTrack® model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings. The GlucoTrack® model DF-F utilizes a combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements via a sensor that is clipped onto one's earlobe and connected to a handheld control and display unit, all without drawing blood or interstitial fluid. The GCTK stock yearly return is shown above.
The yearly return on the GCTK stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2017 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the GCTK annual return calculation with any dividends reinvested as applicable (on ex-dates).
|